NZ599544A - Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same - Google Patents

Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same

Info

Publication number
NZ599544A
NZ599544A NZ599544A NZ59954409A NZ599544A NZ 599544 A NZ599544 A NZ 599544A NZ 599544 A NZ599544 A NZ 599544A NZ 59954409 A NZ59954409 A NZ 59954409A NZ 599544 A NZ599544 A NZ 599544A
Authority
NZ
New Zealand
Prior art keywords
spherical
rigid
calcium phosphate
phosphate particles
active agent
Prior art date
Application number
NZ599544A
Other languages
English (en)
Inventor
Tetsuro Ogawa
Akira Yamamoto
Original Assignee
Lab Skin Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Skin Care Inc filed Critical Lab Skin Care Inc
Publication of NZ599544A publication Critical patent/NZ599544A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ599544A 2008-09-23 2009-09-23 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same NZ599544A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9950008P 2008-09-23 2008-09-23
PCT/US2009/058108 WO2010039560A2 (en) 2008-09-23 2009-09-23 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same

Publications (1)

Publication Number Publication Date
NZ599544A true NZ599544A (en) 2014-04-30

Family

ID=42074119

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ599544A NZ599544A (en) 2008-09-23 2009-09-23 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same

Country Status (17)

Country Link
US (5) US8535723B2 (ja)
EP (1) EP2480210A4 (ja)
JP (1) JP5730316B2 (ja)
KR (4) KR20180089553A (ja)
CN (1) CN102802610A (ja)
AU (1) AU2009298814B2 (ja)
BR (1) BR112012006635B8 (ja)
CA (1) CA2778604C (ja)
CL (1) CL2012000726A1 (ja)
EA (1) EA027992B1 (ja)
IL (2) IL218808A (ja)
MX (1) MX356209B (ja)
MY (1) MY162982A (ja)
NZ (1) NZ599544A (ja)
SG (2) SG10201903125QA (ja)
WO (1) WO2010039560A2 (ja)
ZA (1) ZA201202948B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201903125QA (en) 2008-09-23 2019-05-30 Laboratory Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
WO2010107964A1 (en) * 2009-03-18 2010-09-23 Pleiades Cardio-Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
JP2012526144A (ja) * 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
WO2013025951A1 (en) * 2011-08-16 2013-02-21 Laboratoy Skin Care, Inc. Fine dry particulate adenosine compositions and topical formulations including the same
CA2771358A1 (en) * 2009-08-19 2011-02-24 Sascha General Drug delivery systems (wafer) for pediatric use
WO2011060099A2 (en) * 2009-11-10 2011-05-19 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
SG10201600332TA (en) * 2011-01-19 2016-02-26 Lab Skin Care Inc Topical minocycline compositions and methods of using the same
CN102552913B (zh) * 2012-01-19 2013-06-19 中国科学院上海硅酸盐研究所 一种纳米结构磷酸钙双载药体系及其制备方法
CN103284929B (zh) * 2012-02-23 2015-08-12 黄曦 一种护肤品及其制备方法
US11844852B2 (en) * 2012-02-23 2023-12-19 Fe:I Beauty Tech, Inc. Skincare product and method of preparation thereof
CN102579355B (zh) * 2012-03-19 2013-03-06 天津大学 米托蒽醌纳米磷酸氢钙制剂及其制备方法
CZ2012724A3 (cs) * 2012-10-24 2014-07-23 Agra Group, A.S. Mezoporézní částice, jejich použití a přípravek je obsahující
BR112015023117A2 (pt) * 2013-03-15 2017-07-18 Laboratory Skin Care Inc composições de agente ativo retinóide particulado fino seco e formulações tópicas incluindo as mesmas
WO2014145093A1 (en) * 2013-03-15 2014-09-18 Laboratory Skin Care, Inc. Fine dry particulate resveratrol active agent compositions and topical formulations including the same
CN104856889B (zh) * 2014-09-22 2017-05-10 北京大学口腔医学院 缓释氯己定无定形磷酸钙纳米颗粒的制备方法
CN105336873B (zh) * 2015-11-05 2018-12-07 广州竞择微电子技术有限公司 一种柔性光电子器件用基板及其制备方法
CN114847965A (zh) 2016-02-01 2022-08-05 英凯达治疗公司 电子监测联合吸入药理学疗法管理心律失常
WO2017208209A1 (en) * 2016-06-03 2017-12-07 M et P Pharma AG Nasal pharmaceutical compositions with a porous excipient
CN110461340A (zh) 2017-01-20 2019-11-15 马特恩制药股份公司 用于降低暴露于空气污染物的风险的鼻用药物组合物
WO2018209107A1 (en) 2017-05-10 2018-11-15 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
JP6961504B2 (ja) * 2018-01-26 2021-11-05 国立大学法人 岡山大学 徐放性デバイス
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
KR102221493B1 (ko) * 2018-12-12 2021-02-26 성균관대학교산학협력단 핵산 기반의 칼슘 포스페이트 나노 소재를 합성하는 방법 및 이에 의해 합성된 핵산 기반의 칼슘 포스페이트 나노 소재
US11020384B2 (en) 2019-08-01 2021-06-01 Incarda Therapeutics, Inc. Antiarrhythmic formulation
CN113054121B (zh) * 2019-12-28 2022-07-05 Tcl科技集团股份有限公司 纳米材料及其制备方法、半导体器件

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
JPH0832551B2 (ja) 1989-06-24 1996-03-29 旭光学工業株式会社 多孔質リン酸カルシウム系化合物粒子及びその製造方法
JPH07330319A (ja) * 1994-06-03 1995-12-19 Asahi Optical Co Ltd 皮膚清浄用粉末組成物
US5837728A (en) * 1995-01-27 1998-11-17 Molecular Design International 9-cis retinoic acid esters and amides and uses thereof
US6579516B1 (en) 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US6416774B1 (en) * 1996-05-09 2002-07-09 The Trustees Of The University Of Pennsyvania Hollow bone mineral-like calcium phosphate particles
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
JP2004075662A (ja) * 2002-06-20 2004-03-11 Mukku:Kk 徐放性組成物、その製造方法およびその製剤
AU2004249032A1 (en) 2003-06-18 2004-12-29 Ltt Bio-Pharma Co.,Ltd. Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
FR2856594B1 (fr) * 2003-06-26 2006-03-03 Oreal Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)
US20050031559A1 (en) 2003-07-07 2005-02-10 L'oreal Cosmetic composition for caring for and/or making up skin
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
CA2555921A1 (en) 2004-02-13 2005-09-15 Nod Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of making and using same
US7238363B2 (en) 2004-04-02 2007-07-03 Baylor College Of Medicine Modification of medical prostheses
US20060073205A1 (en) * 2004-10-04 2006-04-06 Kotoe Ohta Controlled release granules comprising porous silica core
US20060257492A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
CN1813657A (zh) * 2005-12-15 2006-08-09 孙振淋 纳米磷酸钙类盐在化妆产品中的应用方法
CN100509695C (zh) * 2006-02-21 2009-07-08 西南交通大学 多孔羟基磷灰石和磷酸钙陶瓷的制备方法
FR2898807B1 (fr) * 2006-03-23 2008-12-05 Oreal Composition comprenant de l'hydroxyapatite et un sel de calcium pour renforcer la fonction barriere de la peau et/ou des semi-muqueuses
CN100460016C (zh) * 2006-04-21 2009-02-11 华南理工大学 介孔磷酸钙纳米颗粒及其制备方法和应用
SG10201903125QA (en) * 2008-09-23 2019-05-30 Laboratory Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
JP2012526144A (ja) * 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
BR112015023117A2 (pt) * 2013-03-15 2017-07-18 Laboratory Skin Care Inc composições de agente ativo retinóide particulado fino seco e formulações tópicas incluindo as mesmas

Also Published As

Publication number Publication date
US10028903B2 (en) 2018-07-24
IL255112A0 (en) 2017-12-31
CL2012000726A1 (es) 2013-01-11
KR20120104188A (ko) 2012-09-20
MX2012003542A (es) 2012-09-07
EP2480210A4 (en) 2016-07-13
EA027992B1 (ru) 2017-09-29
KR101689635B1 (ko) 2016-12-26
KR20160083953A (ko) 2016-07-12
BR112012006635A2 (pt) 2016-05-03
MY162982A (en) 2017-07-31
WO2010039560A2 (en) 2010-04-08
US20100086606A1 (en) 2010-04-08
US20190117558A1 (en) 2019-04-25
EA201290170A3 (ru) 2013-03-29
IL218808A0 (en) 2012-06-28
KR20170096241A (ko) 2017-08-23
US20140199400A1 (en) 2014-07-17
AU2009298814A1 (en) 2012-06-21
KR20180089553A (ko) 2018-08-08
MX356209B (es) 2018-05-18
BR112012006635B8 (pt) 2021-05-25
CN102802610A (zh) 2012-11-28
US20240082147A1 (en) 2024-03-14
US20210015739A1 (en) 2021-01-21
BR112012006635B1 (pt) 2021-04-06
EA201290170A2 (ru) 2012-11-30
SG10201406431QA (en) 2014-11-27
SG10201903125QA (en) 2019-05-30
CA2778604A1 (en) 2010-04-08
IL218808A (en) 2017-10-31
ZA201202948B (en) 2014-08-27
AU2009298814B2 (en) 2016-05-05
US8535723B2 (en) 2013-09-17
JP5730316B2 (ja) 2015-06-10
EP2480210A2 (en) 2012-08-01
US10758478B2 (en) 2020-09-01
JP2013505293A (ja) 2013-02-14
CA2778604C (en) 2021-10-05
WO2010039560A3 (en) 2015-05-21
IL255112B (en) 2019-09-26

Similar Documents

Publication Publication Date Title
NZ599544A (en) Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
WO2009101271A3 (fr) Aerogels de nanotubes de carbone
WO2008123606A1 (ja) 多孔質炭素材料及びその製造方法、並びに、吸着剤、マスク、吸着シート及び担持体
MX2010004292A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea.
WO2012002646A3 (ko) 케이블형 이차전지용 음극 및 이를 구비하는 케이블형 이차전지
WO2013148975A3 (en) Emm-19: zeolitic imidazolate framework material, methods for making same, and uses thereof
JP2009521579A5 (ja)
WO2010129819A3 (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2007010584A3 (en) Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof
WO2019093681A3 (ko) 다공성 탄소, 이를 포함하는 양극 및 리튬 이차전지
US20140370262A1 (en) Three-dimensional graphene structure, and preparation method thereof
WO2013053679A3 (de) Verfahren zur herstellung einer kompositstruktur aus porösem kohlenstoff und elektrochemischem aktivmaterial
Fischer et al. Bioinspired carbide-derived carbons with hierarchical pore structure for the adsorptive removal of mercury from aqueous solution
WO2018081055A3 (en) Host material for stabilizing lithium metal electrode, and fabricating method and applications of same
WO2015145054A3 (fr) Reacteur implantable biocompatible
JP2014067643A5 (ja)
WO2011056775A3 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
WO2009155227A3 (en) Microporous carbon and method for making the same
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
NZ710023A (en) Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods
WO2010120660A3 (en) Method of making active materials for use in secondary electrochemical cells
WO2011031099A3 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same
JO3284B1 (ar) طريقة لعلاج الأرض الزراعية بالغاز
NZ608669A (en) Method and device for vacuum pressure swing adsorption with temporary storage
WO2010121624A3 (en) Improved process for the treatment of a porous material

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 23 SEP 2016 BY FB RICE

Effective date: 20140902

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 SEP 2017 BY FB RICE

Effective date: 20170317

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 SEP 2018 BY FB RICE PTY LTD

Effective date: 20180308

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 SEP 2019 BY FB RICE PTY LTD

Effective date: 20190312

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 SEP 2020 BY FB RICE PTY LTD

Effective date: 20200311

LAPS Patent lapsed